WU 352: Open-label, Randomized Controlled Trial of Hydroxychloroquine Alone or Hydroxychloroquine Plus Azithromycin or Chloroquine Alone or Chloroquine Plus Azithromycin in the Treatment of SARS CoV-2 Infection
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006713/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This Phase III trial four treatment strategies non-critically ill hospitalized participants
(not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection,
Participants will receive hydroxychloroquine or chloroquine with or without azithromycin.
提供机构：
Vivli
创建时间：
2021-02-24
